l-750667 and Colitis
l-750667 has been researched along with Colitis* in 1 studies
Other Studies
1 other study(ies) available for l-750667 and Colitis
| Article | Year |
|---|---|
Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses.
Berberine is an herbal alkaloid with various biological activities, including anti-inflammatory and antidepressant effects. Here, we examined the effects of berberine on dopamine receptors and the ensuing anti-inflammatory responses. Berberine was found to be an antagonist at both dopamine D1- and D2-like receptors and ameliorates the development of experimentally induced colitis in mice. In lipopolysaccharide-stimulated immune cells, berberine treatment modified cytokine levels, consistent with the effects of the dopamine receptor specific antagonists SCH23390 and L750667. Our findings indicate that dopamine receptor antagonists suppress innate and adaptive immune responses, providing a foundation for their use in combatting inflammatory diseases. Topics: Adaptive Immunity; Animals; Benzazepines; Berberine; Bone Marrow; Colitis; Cytokines; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Dopamine Antagonists; Immunity, Innate; Lipopolysaccharides; Lymph Nodes; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Protein Binding; Pyridines; Pyrroles; Receptors, Dopamine; Receptors, Serotonin; Time Factors | 2015 |